Á¤½Å¾à¹°Ä¡·á Áöħ¼
¹Ú¿¬Èñ,±èÈñ¼÷,ÀÌÇý°æ °øÀú | Á¤´ã¹Ìµð¾î
Ãâ°£ÀÏ 2012³â 09¿ù 01ÀÏ
184ÂÊ | 502g | 188*254mm
¡Ø Ã¥¼Ò°³
Çö´ë¿¡ À̸£·¯ Á¤½Å °ü·Ã º´µéÀÌ ´Ã¾î³ª¸é¼ ÀÌ¿¡ µû¸¥ Á¤½Å¾à¹°Ä¡·á¿¡ ´ëÇÑ °ü½Éµµ ±ÞÁõÇÏ°í ÀÖ´Ù. Á¤½ÅÄ¡·á ÇÏ´Â µ¥ ÀÖ¾î¼ Áß¿äÇÑ ºÎºÐÀ» Â÷ÁöÇÏ´Â ¾à¹°Ä¡·á¿¡ °üÇØ ÃֽŠÁ¤º¸·Î °³Á¤µÇ¾ú´Ù. ÇöÀç ½Ç¹«¿¡¼ Á¤½Åº´¿øÀ̳ª Á¤½Åº´µ¿¿¡¼ ±Ù¹«ÇÏ´Â °£È£»çµé, Áö¿ª»çȸ Á¤½Åº¸°Ç °ü·Ã ±â°ü¿¡¼ ±Ù¹«ÇÏ´Â °£È£»ç ¿Ü Á¤½Åº¸°Ç¿ä¿øµé¿¡°Ô Á¤½Å¾à¹°¿¡ ´ëÇÑ Áö½Ä°ú »õ·Î¿î ¾à¹°¿¡ ´ëÇÑ ÀÌÇظ¦ ³ôÀ̱â À§ÇØ Àú¼úµÇ¾ú´Ù. Á¤½ÅÀå¾ÖÀε鿡°Ô ¾à¹°¼øÀÀÀ» ³ôÀÌ°í ±Ù°ÅÁ᫐ ½Ç¹«°¡ µÇµµ·Ï ÀçÁ¤¸®ÇÏ¿´´Ù. ÃÖ¼± Á¤½Å¾à¹°ÇÐ ¼ÀûµéÀ» Âü°íÇÏ¿© Á¤½Å¾à¹°ÀÇ ºÐ·ù, ÀÛ¿ë, ºÎÀÛ¿ë, ¾à¹° »óÈ£ÀÛ¿ë, ±âŸ ¾à¹° °ü·Ã Áö½Ä ¹× ±³À°³»¿ëµéÀÌ ¼ö·ÏµÇ¾ú´Ù.
¡Ø ¸ñÂ÷
I Á¤½Å¾à¹°Ä¡·áÀÇ ÀϹÝÀû Áöħ
II Á¤½Å¾à¹°ÇÐÀÇ ¿ª»ç
III ¾à¹° »óÈ£ÀÛ¿ë
3.1 ¾à¿ªÇÐ(Pharmacodynamics)
3.2 ¾àµ¿ÇÐ(Pharmacikinetics)
IV ¾à¹°ÀÇ ºÐ·ù
4.1 Ç×Á¤½Åº´¾à¹°(Antipsychotic drug, Neuroleptics)
4.2 ÃßÁ¦¿Ü·Î°è Áõ»óÀ» Ä¡·áÇÏ´Â ¾à¹°(Adjunctive Medications for EPSs)
4.3 Ç׿ì¿ïÁ¦(Antidepressants)
4.4 ±âºÐ¾ÈÁ¤Á¦(Mood stavilizers, Antimanic drug)
4.5 Ç׺ҾÈÁ¦(Antianxiety drugs, Anxiolytics)
4.6 ¼ö¸éÁ¦/ÁøÁ¤Á¦(Hypnotics/Sedatives)
4.7 Ç×°æ·ÃÁ¦(Anticonvulsants)
4.9 ÀÎÁö±â´É °³¼±Á¦(Cognitive engancers, Noogenics)
Âü°í¹®Çå
ã¾Æº¸±â